IDEAS home Printed from https://ideas.repec.org/r/aea/aejpol/v10y2018i4p1-35.html
   My bibliography  Save this item

Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Agustina Laurito, 2024. "Spillovers of the Heroin Epidemic on Grandparent Caregiving," Population Research and Policy Review, Springer;Southern Demographic Association (SDA), vol. 43(2), pages 1-25, April.
  2. Janet Currie & Hannes Schwandt, 2021. "The Opioid Epidemic Was Not Caused by Economic Distress but by Factors That Could Be More Rapidly Addressed," The ANNALS of the American Academy of Political and Social Science, , vol. 695(1), pages 276-291, May.
  3. Suppliet, Moritz, 2020. "Umbrella branding in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 73(C).
  4. Aliprantis, Dionissi & Fee, Kyle & Schweitzer, Mark E., 2023. "Opioids and the labor market," Labour Economics, Elsevier, vol. 85(C).
  5. Zambiasi, Diego, 2022. "Drugs on the Web, Crime in the Streets. The Impact of Shutdowns of Dark Net Marketplaces on Street Crime," Journal of Economic Behavior & Organization, Elsevier, vol. 202(C), pages 274-306.
  6. Louis‐Philippe Beland & Jason Huh & Dongwoo Kim, 2024. "The effect of opioid use on traffic fatalities," Health Economics, John Wiley & Sons, Ltd., vol. 33(6), pages 1123-1132, June.
  7. Martin Andersen & Johanna Catherine Maclean & Michael F. Pesko & Kosali Simon, 2023. "Does paid sick leave encourage staying at home? Evidence from the United States during a pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 32(6), pages 1256-1283, June.
  8. Sydelko, Pamela & Midgley, Gerald & Espinosa, Angela, 2021. "Designing interagency responses to wicked problems: Creating a common, cross-agency understanding," European Journal of Operational Research, Elsevier, vol. 294(1), pages 250-263.
  9. Mark McInerney, 2017. "The Affordable Care Act, Public Insurance Expansion and Opioid Overdose Mortality," Working papers 2017-23, University of Connecticut, Department of Economics.
  10. Casey B. Mulligan, 2020. "Prices and Federal Policies in Opioid Markets," Working Papers 2020-10, Becker Friedman Institute for Research In Economics.
  11. Denis Agniel & Jonathan H. Cantor & Johanna Catherine Maclean & Kosali I. Simon & Erin Taylor, 2023. "Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare," NBER Working Papers 31884, National Bureau of Economic Research, Inc.
  12. Deiana, Claudio & Giua, Ludovica, 2018. "The US Opidemic: Prescription Opioids, Labour Market Conditions and Crime," MPRA Paper 85712, University Library of Munich, Germany.
  13. Alexander Ahammer & Martin Halla, 2020. "The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data," Economics working papers 2020-10, Department of Economics, Johannes Kepler University Linz, Austria.
  14. Adamopoulou, Effrosyni & Greenwood, Jeremy & Guner, Nezih & Kopecky, Karen, 2024. "The Role of Friends in the Opioid Epidemic," CEPR Discussion Papers 18803, C.E.P.R. Discussion Papers.
  15. Cohle, Zachary & Ortega, Alberto, 2023. "The effect of the opioid crisis on patenting," Journal of Economic Behavior & Organization, Elsevier, vol. 214(C), pages 493-521.
  16. Alberto Ortega, 2023. "Medicaid Expansion and mental health treatment: Evidence from the Affordable Care Act," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 755-806, April.
  17. Graham, Francis W. & de New, Sonja C. & Nielsen, Suzanne & Petrie, Dennis, 2023. "Revisiting the OxyContin Reformulation: The Role of Licit Substitutes," IZA Discussion Papers 16653, Institute of Labor Economics (IZA).
  18. Molly Schnell & Janet Currie, 2018. "Addressing the Opioid Epidemic: Is There a Role for Physician Education?," American Journal of Health Economics, University of Chicago Press, vol. 4(3), pages 383-410, Summer.
  19. Ahomäki, Iiro & Böckerman, Petri & Pehkonen, Jaakko & Saastamoinen, Leena, 2024. "Effect of an Information Intervention on Opioid Prescribing: A Preregistered Nationwide Randomized Experiment," IZA Discussion Papers 17416, Institute of Labor Economics (IZA).
  20. Zai, Xianhua, 2024. "Beyond the brink: Unraveling the opioid crisis and its profound impacts," Economics & Human Biology, Elsevier, vol. 53(C).
  21. Cotti, Chad D. & Gordanier, John M. & Ozturk, Orgul D., 2020. "The relationship of opioid prescriptions and the educational performance of children," Social Science & Medicine, Elsevier, vol. 265(C).
  22. Sim, Yongbo, 2023. "The effect of opioids on crime: Evidence from the introduction of OxyContin," International Review of Law and Economics, Elsevier, vol. 74(C).
  23. Diego Zambiasi, 2020. "Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime," Working Papers 202025, School of Economics, University College Dublin.
  24. Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
  25. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
  26. Ritter, Patricia I., 2023. "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home," Economics & Human Biology, Elsevier, vol. 51(C).
  27. Natali, Ilaria, 2024. "Economic Opportunity and Opioid Regulation: the Case of Codeine in France," TSE Working Papers 24-1563, Toulouse School of Economics (TSE).
  28. Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020. "How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D," Journal of Health Economics, Elsevier, vol. 71(C).
  29. Amy Finkelstein & Matthew Gentzkow & Dean Li & Heidi L. Williams, 2022. "What Drives Risky Prescription Opioid Use? Evidence from Migration," NBER Working Papers 30471, National Bureau of Economic Research, Inc.
  30. Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," NBER Working Papers 29596, National Bureau of Economic Research, Inc.
  31. Dhaval Dave & Monica Deza & Brady Horn, 2021. "Prescription drug monitoring programs, opioid abuse, and crime," Southern Economic Journal, John Wiley & Sons, vol. 87(3), pages 808-848, January.
  32. Grossmann, Volker & Strulik, Holger, 2021. "Illicit drugs and the decline of the middle class," Journal of Economic Behavior & Organization, Elsevier, vol. 183(C), pages 718-743.
  33. Deiana Claudio & Giua Ludovica, 2021. "The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 21(2), pages 751-792, April.
  34. Buckles, Kasey & Evans, William N. & Lieber, Ethan M.J., 2023. "The drug crisis and the living arrangements of children," Journal of Health Economics, Elsevier, vol. 87(C).
  35. William N. Evans & Ethan M. J. Lieber & Patrick Power, 2019. "How the Reformulation of OxyContin Ignited the Heroin Epidemic," The Review of Economics and Statistics, MIT Press, vol. 101(1), pages 1-15, March.
  36. Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2020. "Prescription drug monitoring programs and neonatal outcomes," Regional Science and Urban Economics, Elsevier, vol. 81(C).
  37. Park, Sujeong & Powell, David, 2021. "Is the rise in illicit opioids affecting labor supply and disability claiming rates?," Journal of Health Economics, Elsevier, vol. 76(C).
  38. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
  39. Porreca, Zachary, 2024. "Identifying the General Equilibrium Effects of Narcotics Enforcement," GLO Discussion Paper Series 1455, Global Labor Organization (GLO).
  40. Christopher J. Ruhm, 2018. "Deaths of Despair or Drug Problems?," NBER Working Papers 24188, National Bureau of Economic Research, Inc.
  41. Meinhofer, Angélica & Witman, Allison E., 2018. "The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion," Journal of Health Economics, Elsevier, vol. 60(C), pages 177-197.
  42. Evan D. Peet & David Powell & Rosalie Liccardo Pacula, 2024. "Using Policy and Innovation to Improve Life-Saving Access to Naloxone," NBER Working Papers 33105, National Bureau of Economic Research, Inc.
  43. McMichael, Benjamin J. & Van Horn, R. Lawrence & Viscusi, W. Kip, 2020. "The impact of cannabis access laws on opioid prescribing," Journal of Health Economics, Elsevier, vol. 69(C).
  44. David Beheshti, 2019. "Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin," Health Economics, John Wiley & Sons, Ltd., vol. 28(12), pages 1449-1461, December.
  45. Aparna Keshaviah & Editor, "undated". "Special Report: The Potential of Wastewater Testing for Public Health and Safety," Mathematica Policy Research Reports 5a867fbc382040a1af74f957b, Mathematica Policy Research.
  46. Diwas KC & TI Tongil Kim & Jiayi Liu, 2022. "Electronic prescription monitoring and the opioid epidemic," Production and Operations Management, Production and Operations Management Society, vol. 31(11), pages 4057-4074, November.
  47. Gupta, Sumedha & Nguyen, Thuy & Freeman, Patricia R. & Simon, Kosali, 2023. "Competitive effects of federal and state opioid restrictions: Evidence from the controlled substance laws," Journal of Health Economics, Elsevier, vol. 91(C).
  48. Colleen Heflin & Xiaohan Sun, 2022. "Food Insecurity and the Opioid Crisis," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 262-284, September.
  49. Mitchell, Penelope & Samsel, Steven & Curtin, Kevin M. & Price, Ashleigh & Turner, Daniel & Tramp, Ryan & Hudnall, Matthew & Parton, Jason & Lewis, Dwight, 2022. "Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior," Social Science & Medicine, Elsevier, vol. 302(C).
  50. Justine S. Hastings & Mark Howison & Sarah E. Inman, 2020. "Predicting high-risk opioid prescriptions before they are given," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, vol. 117(4), pages 1917-1923, January.
  51. Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2024. "Opium Price Shocks and Prescription Opioids in the USA," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 86(3), pages 449-484, June.
  52. Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
  53. Christopher J. Ruhm, 2019. "Shackling the Identification Police?," Southern Economic Journal, John Wiley & Sons, vol. 85(4), pages 1016-1026, April.
  54. Lindsey Rose Bullinger & Benjamin C. Ward, 2021. "What about the children? How opioid use affects child well‐being," Contemporary Economic Policy, Western Economic Association International, vol. 39(4), pages 737-759, October.
  55. David M. Cutler & J. Travis Donahoe, 2024. "Thick Market Externalities and the Persistence of the Opioid Epidemic," NBER Working Papers 32055, National Bureau of Economic Research, Inc.
  56. Robert Bifulco & Iuliia Shybalkina, 2022. "Fiscal Impacts of the Opioid Crisis on State and Local Governments," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 324-349, September.
  57. Daniele, Gianmarco & Le Moglie, Marco & Masera, Federico, 2023. "Pains, guns and moves: The effect of the U.S. opioid epidemic on Mexican migration," Journal of Development Economics, Elsevier, vol. 160(C).
  58. Casey B. Mulligan, 2020. "Prices and Federal Policies in Opioid Markets," NBER Working Papers 26812, National Bureau of Economic Research, Inc.
  59. d'Este, Rocco, 2022. "Scientific Advancements in Illegal Drugs Production and Institutional Responses: New Psychoactive Substances, Self-Harm, and Violence inside Prisons," IZA Discussion Papers 15248, Institute of Labor Economics (IZA).
  60. Freylejer, Leandro & Orr, Scott, 2023. "Import substitution in illicit methamphetamine markets," Journal of International Economics, Elsevier, vol. 140(C).
  61. David Powell & Rosalie Liccardo Pacula, 2021. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," American Journal of Health Economics, University of Chicago Press, vol. 7(1), pages 41-67.
  62. Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2020. "How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program," Health Economics, John Wiley & Sons, Ltd., vol. 29(9), pages 957-974, September.
  63. Sumedha Gupta & Morhaf Al Achkar & Bradley Ray, 2022. "Are prescription drug monitoring laws effective for all? Evidence from administrative data," Contemporary Economic Policy, Western Economic Association International, vol. 40(1), pages 28-47, January.
  64. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
  65. Johanna Catherine Maclean & Chandler McClellan & Michael F. Pesko & Daniel Polsky, 2023. "Medicaid reimbursement rates for primary care services and behavioral health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 873-909, April.
  66. Kalbfuss, Jörg & Odermatt, Reto & Stutzer, Alois, 2024. "Medical marijuana laws and mental health in the United States," Health Economics, Policy and Law, Cambridge University Press, vol. 19(3), pages 307-322, July.
  67. Kim, Bokyung, 2021. "Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences," Journal of Health Economics, Elsevier, vol. 75(C).
  68. Mir M. Ali & Chandler McClellan & Ryan Mutter & Daniel I. Rees, 2023. "Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata," Health Economics, John Wiley & Sons, Ltd., vol. 32(2), pages 277-301, February.
  69. Alexander Cardazzi & Joshua C. Martin & Zachary Rodriguez, 2023. "Information shocks and celebrity exposure: The effect of “Magic” Johnson on AIDS diagnoses and mortality in the U.S," Health Economics, John Wiley & Sons, Ltd., vol. 32(9), pages 2047-2079, September.
  70. Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.
  71. Martin Andersen & Johanna Catherine Maclean & Michael F. Pesko & Kosali I. Simon, 2020. "Paid sick-leave and physical mobility: Evidence from the United States during a pandemic," NBER Working Papers 27138, National Bureau of Economic Research, Inc.
  72. Patricia I. Ritter & Ricardo A. Sanchez, 2023. "The effects of an epidemic on prenatal investments, childhood mortality and health of surviving children," Journal of Population Economics, Springer;European Society for Population Economics, vol. 36(1), pages 505-544, January.
  73. Bullinger, Lindsey Rose & Wing, Coady, 2019. "How many children live with adults with opioid use disorder?," Children and Youth Services Review, Elsevier, vol. 104(C), pages 1-1.
  74. Janet Currie & Hannes Schwandt, 2020. "The Opioid Epidemic Was Not Primarily Caused by Economic Distress But by Other Factors that Can be More Readily Addressed," Working Papers 2020-25, Princeton University. Economics Department..
  75. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," Journal of Economic Perspectives, American Economic Association, vol. 35(4), pages 171-196, Fall.
  76. Lucy Xiaolu Wang, 2021. "The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2026-2046, September.
  77. Pohl, R. Vincent, 2018. "Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality," MPRA Paper 87237, University Library of Munich, Germany.
  78. Doleac, Jennifer & Mukherjee, Anita, 2018. "The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime," IZA Discussion Papers 11489, Institute of Labor Economics (IZA).
  79. David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
  80. Sacks, Daniel W. & Hollingsworth, Alex & Nguyen, Thuy & Simon, Kosali, 2021. "Can policy affect initiation of addictive substance use? Evidence from opioid prescribing," Journal of Health Economics, Elsevier, vol. 76(C).
  81. Patrick A. McLaughlin & Casey B. Mulligan, 2020. "Three Myths about Federal Regulation," NBER Working Papers 27233, National Bureau of Economic Research, Inc.
  82. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
  83. Alice M. Ellyson & Jevay Grooms & Alberto Ortega, 2022. "Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 297-341, February.
  84. Shiyu Zhang & Daniel Guth, 2021. "The OxyContin Reformulation Revisited: New Evidence From Improved Definitions of Markets and Substitutes," Papers 2101.01128, arXiv.org, revised Jan 2021.
  85. Jessica Pac & Christine Durrance & Lawrence Berger & Deborah B. Ehrenthal, 2022. "The Effects of Opioid Use during Pregnancy on Infant Health and Well-Being," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 106-138, September.
  86. Jacob N. Miller, 2020. "The War On Drugs 2.0: Darknet Fentanyl'S Rise And The Effects Of Regulatory And Law Enforcement Action," Contemporary Economic Policy, Western Economic Association International, vol. 38(2), pages 246-257, April.
  87. Borgschulte, Mark & Corredor-Waldron, Adriana & Marshall, Guillermo, 2018. "A path out: Prescription drug abuse, treatment, and suicide," Journal of Economic Behavior & Organization, Elsevier, vol. 149(C), pages 169-184.
  88. Böckerman, Petri & Kortelainen, Mika & Laine, Liisa T. & Nurminen, Mikko & Saxell, Tanja, 2019. "Digital Waste? Unintended Consequences of Health Information Technology," Working Papers 117, VATT Institute for Economic Research.
  89. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
  90. Carolina Arteaga Cabrales & Victoria Barone, 2021. "The Opioid Epidemic: Causes and Consequences," Working Papers tecipa-698, University of Toronto, Department of Economics.
  91. Alexander Ahammer, 2019. "A novel supply-side measure to combat abuse of addictive prescription drugs," Economics working papers 2019-11, Department of Economics, Johannes Kepler University Linz, Austria.
  92. Schwab, Thomas & Todtenhaupt, Maximilian, 2021. "Thinking outside the box: The cross-border effect of tax cuts on R&D," Journal of Public Economics, Elsevier, vol. 204(C).
  93. Bhashkar Mazumder, 2023. "The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes," Working Paper Series WP 2023-13, Federal Reserve Bank of Chicago.
  94. Casey B. Mulligan, 2022. "Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21," NBER Working Papers 29719, National Bureau of Economic Research, Inc.
  95. Gal Wettstein, 2019. "Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 666-677, May.
  96. Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2018. "The Effects of Mandatory Prescription Drug Monitoring Programs on Foster Care Admissions," IZA Discussion Papers 11470, Institute of Labor Economics (IZA).
  97. Abouk, Rahi & Powell, David, 2021. "Can electronic prescribing mandates reduce opioid-related overdoses?," Economics & Human Biology, Elsevier, vol. 42(C).
  98. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," NBER Working Papers 28873, National Bureau of Economic Research, Inc.
  99. Daniel I. Rees & Joseph J. Sabia & Laura M. Argys & Joshua Latshaw & Dhaval Dave, 2017. "With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths," NBER Working Papers 23171, National Bureau of Economic Research, Inc.
  100. Ruhm, Christopher J., 2019. "Drivers of the fatal drug epidemic," Journal of Health Economics, Elsevier, vol. 64(C), pages 25-42.
  101. Alexander Cardazzi & Joshua Martin & Zachary Rodriguez, 2021. "Information Avoidance and Celebrity Exposure: The Effect of "Magic" Johnson on AIDS Diagnoses and Mortality in the U.S," Working Papers 21-04, Department of Economics, West Virginia University.
  102. Rocco d'Este, 2021. "Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses," Economica, London School of Economics and Political Science, vol. 88(349), pages 208-233, January.
  103. Alexander Ahammer & Martin Halla, 2022. "The intergenerational persistence of opioid dependence: Evidence from administrative data," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2425-2444, November.
  104. Rose, C.; & Williams, J.; & Bretteville-Jensen, A.L.;, 2024. "Do Peers Support or Subvert Recovery from Substance Use Disorders," Health, Econometrics and Data Group (HEDG) Working Papers 24/18, HEDG, c/o Department of Economics, University of York.
  105. Janssen, Aljoscha & Zhang, Xuan, 2020. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," Working Paper Series 1373, Research Institute of Industrial Economics.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.